Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo.
John W Steele,
Soong H Kim,
John R Cirrito,
Deborah K Verges,
Jessica L Restivo,
David Westaway,
Paul Fraser,
Peter St George Hyslop,
Mary Sano,
Ilya Bezprozvanny,
Michelle E Ehrlich,
David M Holtzman,
Sam Gandy
OAI: oai:www.repository.cam.ac.uk:1810/237882